Successfully tested 'metastatic cancer vaccine'

With similar immunosuppression mechanisms, US scientists have removed both the main tumor and distant metastases in the bodies of experimental mice with cancer.

The Stanford University School of Medicine (USA) calls for volunteers who are suffering from the leading type of cancer of the lymphoma - to participate in human trials, after successful animal testing. nice

Professor Ronald Levy at the laboratory - (Photo: STANDFORD MEDICAL UNIVERSITY).

Dr. Ronald Levy, a key member of the research team, said the new therapy not only completely removed cancer traces at distant metastases, but also a similar method. inexpensive, does not cause side effects commonly found in other immunostimulatory therapies.

The team used two immunostimulants to activate in tumors that automatically suppress the body's immune system. Since this is the battle of the immune system, not only the central tumors but also distant metastases are destroyed.

According to Professor Levy, usually immune cells such as T cells have found abnormal proteins that appear in cancer. However, when the tumor grows, it often finds a way to prevent T-cell activity. So it is the scientists' task to stimulate T cells to rise and function strongly.

Currently, one of two types of immune stimulants has been approved by a competent authority, allowing use on humans. Scientists are just waiting for the second substance to be approved and enough volunteers for the next step. If the experiment continues to be successful in patients with incurable lymphoma, it will be a major breakthrough in the cancer industry.